预后标志物-话题@MedSci

#预后标志物#

29篇内容 | 1996人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1542686, encodeId=70da1542686f1, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, objectType=article, longId=158432, objectId=5b21158432fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b21158432fa, replyNumber=0, likeNumber=91, createdTime=2019-01-20, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b21158432fa, moduleTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b21158432fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542685, encodeId=a4941542685d8, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, objectType=article, longId=151371, objectId=877a1513e1a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877a1513e1a3, replyNumber=0, likeNumber=41, createdTime=2018-10-20, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877a1513e1a3, moduleTitle=Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877a1513e1a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542684, encodeId=957615426847d, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤, objectType=article, longId=150551, objectId=840e1505514b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=840e1505514b, replyNumber=0, likeNumber=74, createdTime=2018-10-09, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=840e1505514b, moduleTitle=Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=840e1505514b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542683, encodeId=b702154268312, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物, objectType=article, longId=149622, objectId=7008149622a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7008149622a9, replyNumber=0, likeNumber=60, createdTime=2018-09-27, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7008149622a9, moduleTitle=Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7008149622a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542682, encodeId=0102154268273, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点, objectType=article, longId=118805, objectId=dfe711880501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfe711880501, replyNumber=0, likeNumber=0, createdTime=2017-11-06, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfe711880501, moduleTitle=Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfe711880501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542681, encodeId=44131542681b2, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路, objectType=article, longId=111753, objectId=336d111e5353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336d111e5353, replyNumber=0, likeNumber=83, createdTime=2017-09-04, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336d111e5353, moduleTitle=Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=336d111e5353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542680, encodeId=b79b154268046, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？, objectType=article, longId=100483, objectId=16fd1004836f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16fd1004836f, replyNumber=0, likeNumber=72, createdTime=2017-06-03, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16fd1004836f, moduleTitle=CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16fd1004836f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542679, encodeId=9a7d15426e932, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物, objectType=article, longId=94233, objectId=67f19423360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67f19423360, replyNumber=0, likeNumber=37, createdTime=2017-04-02, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67f19423360, moduleTitle=HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67f19423360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542678, encodeId=2b3515426e86a, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物, objectType=article, longId=85442, objectId=04e9854427f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04e9854427f, replyNumber=0, likeNumber=84, createdTime=2016-12-26, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04e9854427f, moduleTitle=Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04e9854427f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542677, encodeId=641f15426e791, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, objectType=article, longId=63098, objectId=b602630980d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b602630980d, replyNumber=0, likeNumber=76, createdTime=2016-02-10, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b602630980d, moduleTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b602630980d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542676, encodeId=775315426e65e, content=<a href='/topic/show?id=3ef610019167' target=_blank style='color:#2F92EE;'>#预后标志物#</a>, objectTitle=NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者, objectType=article, longId=62483, objectId=1b9762483b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b9762483b8, replyNumber=0, likeNumber=63, createdTime=2016-01-24, rootId=0, userName=ms7514935887898259, userId=b24e13440329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b9762483b8, moduleTitle=NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b9762483b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

预后标志物

2020-05-29

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关

2019-01-20

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Biomarkers：染色体3是近距离放射治疗葡萄膜黑色素瘤的有效预后标志物

2018-10-20

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Blood：TLT-1是ALI/ARDS的独立的预后标志物，可减轻急性肺损伤

2018-10-09

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Blood：二代测序证实最小残余病灶可作为多发性骨髓瘤的预后标志物

2018-09-27

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Onco Targets Ther：LOC440040或是前列腺癌新的预后标志物及治疗靶点

2017-11-06

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Oncotarget：研究发现鼻咽癌新的诊断及预后标志物，或为其治疗开辟新的道路

2017-09-04

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

CLIN CHEM：什么是有效的急性缺血性卒中预后标志物？

2017-06-03

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

HEPATOLOGY：上海药物所揭示 pIgR/p-Yes 亚群分型是肝癌患者生存的预后标志物

2017-04-02

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

Clin Cancer Res：血液中肿瘤DNA可作为胰腺癌的预后标志物

2016-12-26

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

JCO：肿瘤淋巴细胞浸润可以作为预后标志物

2016-02-10

ms7514935887898259 (审核中...)

前往app查看评论内容

#预后标志物#

NEJM：CDX2作为预后标志物可用于识别高风险二期结肠癌患者

2016-01-24

科室
- - 订阅+
  - 更多科室
工具
服务